niagenbioscience.com (NAGE): Earnings per share for the last twelve months
Expanding partnerships in the dietary supplement segment and Niagen deliveries for cell regeneration are creating strong momentum for Chromadex Corp (NAGE). The TTM net income per share snapshot visualizes this trend, with the metric currently at 0.12. Stable revenue is driven by B2B raw material sales to pharmaceutical companies, while the development of longevity technologies relies on collaboration with the world's leading scientific centers.
Analytical breakdowns for niagenbioscience.com (NAGE)
- stock price and consensus target price:
- stock exchange capitalization data:
- shareholders' equity book value data:
- debt burden and liquidity indicators:
Debt to Equity Chromadex Corp|NAGE - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio Chromadex Corp|NAGE - Company Aggregate Debts|Debt to Book Capitalization Ratio ChromaDex Corporation|NAGE - Company Long-Term Liabilities|Company Short-Term Debts ChromaDex|Quick Liquidity niagenbioscience.com
- earnings and multiples data:
NAGE - Company Profit|Future Profit Chromadex Corp|NAGE - Market Price to Net Income Ratio|Future Price to Earnings ChromaDex Corp|NAGE - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple ChromaDex Corporation|NAGE - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) ChromaDex|NAGE - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months niagenbioscience.com|NAGE - Earnings per share increase in current year|Net earnings per share growth forecast for next year Chromadex Corp
- total revenue and sales volume data:
Analysis of all company metrics:NAGE - ChromaDex Corp
For Chromadex Corp (NAGE), this indicator serves as a measure of real business efficiency amid geopolitical restrictions on chemical procurement and the complexities of molecule certification. The metric is calculated as the ratio of net income to the total number of shares, reflecting the portion of earnings attributable to a single share. Analyzing the rolling annual earnings per share allows for an assessment of capital resilience against external logistical shocks.
Competitor analysis
Intuitive Surgical, Inc. - Net earnings per share (EPS TTM)|DHR (Danaher Corporation) - Earnings per share for the last 12 months|Becton Dickinson & Company (BDX) - Earnings per share for the last twelve months|STE - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months WST|BAX (baxter.com) - Earnings per share for the last four quarters|Net earnings per share for the last 12 months MASI (Masimo Corporation)|Earnings per share for the last four quarters STVN|Teleflex Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year MMSI|NVST: Net earnings per share for the last 12 months|ICUI - Net earnings per share (EPS TTM)|Dentsply Sirona Inc (XRAY) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months LeMaitre Vascular|ATRC (atricure.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months STAAR Surgical Co STAA|Earnings per share for the last twelve months ZimVie (ZIMV)|AngioDynamics - Earnings per share for the last 12 months|Cerus Corporation - Net earnings per share for the last 12 months|Earnings per share for the last four quarters TKNO (Alpha Teknova)|MGRM - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Sharps Technology STSS|INFU: Net earnings per share (EPS TTM)|Utah Medical Products, Inc. (UTMD) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months KORU Medical Systems, Inc.|Net earnings per one share for the last twelve months Nyxoah, S.A. NYXH|Net earnings per share (EPS TTM) MBOT|PDEX - Net earnings per one share for the last twelve months|Zentek Limited - Net earnings per share for the last 12 months|Earnings per share for the last four quarters ELUT (Elutia Inc.)|MLSS - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months NEXGEL Inc.|RVP (retractable.com) - Net earnings per share for the last 12 months|Harvard Bioscience, Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months femasys.com|Net earnings per share for the last 12 months MeihuaMed (MHUA)|Net earnings per share (EPS TTM) POAI|Earnings per share for the last four quarters CJMB|Earnings per share for the last twelve months atrioncorp.com ATRI|Earnings per share for the trailing year NURO
